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ABSTRACT 
The aim of this study was to evaluate in vitro the probiotic potential and absorption of Saccharomyces 
cerevisiae for the aflatoxin B1 in simulated fish intestinal tract conditions. Three yeast strains were used, 
two from brewery: S. cerevisiae RC1 and S. cerevisiae RC3 and one from a fish farming environment: S. 
cerevisiae A8L2. The selected yeasts were subjected to the following in vitro tests: homologous 
inhibition, self-aggregation, co-aggregation, antibacterial activity, gastrointestinal conditions tolerance 
and adsorption of AFB1. All S. cerevisiae strains showed good capability of self-aggregation and co-
aggregation with pathogenic bacteria. All yeast strains were able to survive the gastrointestinal 
conditions. In acidic conditions, the factors (strain vs. time) had interaction (P=0.0317), resulting in 
significant variation among the strains tested in the time periods analyzed. It was observed that there was 
also interaction (P=0.0062) in intestinal conditions, with an increased number of cells in the 12-hour 
period for all strains tested. In the adsorption test, the A8L2 strain was statistically more effective 
(P<0.005) for both AFB1 concentrations evaluated in this study (10 and 25ng/mL). Thus, it was observed 
that the strains of S. cerevisiae have potential probiotic and adsorbent of AFB1.  
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RESUMO 
Objetivou-se, com esta pesquisa, avaliar in vitro o potencial probiótico e adsorvente de Saccharomyces 
cerevisiae para aflatoxina B1 em condições simuladas do trato intestinal de peixes. Foram utilizadas três 
cepas de leveduras, sendo duas provenientes de cervejaria: S. cerevisiae RC1 e S. cerevisiae RC3, e uma 
de ambiente de piscicultura: S. cerevisiae A8L2. As leveduras selecionadas foram submetidas aos 
seguintes testes in vitro: inibição homóloga, autoagregação, coagregação, atividade antibacteriana, 
viabilidade às condições gastrointestinais e adsorção de AFB1. Todas as estirpes de S. cerevisiae 
mostraram boa capacidade de autoagregação e coagregação com bactérias patogênicas. Todas as 
estirpes de levedura foram capazes de sobreviver às condições gastrointestinais. Em condições ácidas, os 
fatores (cepa x tempo) tiveram interação (P=0,0317), resultando em variações significativas entre as 
cepas testadas nos períodos de tempo analisados. Observou-se que também houve interação (P=0,0062) 
em condições intestinais, havendo um aumento do número de células no período de 12h para todas as 
cepas avaliadas. No ensaio de adsorção, a estirpe A8L2 foi a mais eficaz estatisticamente (P<0,005), 
para as duas concentrações de AFB1 avaliadas neste estudo (10 e 25ng. mL
-1
). Dessa forma, conclui-se 
que as cepas de Saccharomyces cerevisiae possuem potencial probiótico e adsorvente de AFB1. 
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INTRODUCTION 
 
Aflatoxins are toxic metabolites of importance in 
fishery activities, since their presence has 
significant negative economic impacts and may 
cause serious health problems for aquatic 
species. Among the species diversity, the fish 
known as tambaquis (Colossoma macropomum) 
stands out for its easy adaptability to different 
environmental and handling conditions, 
presenting as a highlight of the global fishing 
industry. Mycotoxin contamination in aquatic 
species occurs mainly by ingestion of 
contaminated feed, as increase in vegetable use 
in feedstuffs has increasingly caused the 
presence of these toxic substances in these 
products (Calvet et al., 2015). 
 
Due to the great importance of aflatoxin B1 
(AFB1) in animal production and its carcinogenic 
and hepatotoxic potential, the search for 
adsorbents able to capture these toxins in the 
gastrointestinal tract and reduce the harmful 
effects of mycotoxicosis on animal health has 
increased (Richard and Payne, 2003). The use of 
physical, chemical and biological control 
mechanisms is constantly being researched, 
providing meaningful ways to reduce toxic food 
contaminants (Richard and Payne, 2003; Pereyra 
et al., 2015).  
 
Among biological methods, microbial 
detoxification is a promising alternative for 
reducing mycotoxin levels. Its effectiveness is 
based on the action of specific chemical 
compounds produced by a given microorganism. 
The use of functional foods containing beneficial 
microorganisms can assist in the mycotoxin 
decontamination process (Pereyra et al., 2015; 
Armando et al., 2011). Probiotic strains formed 
by Generally Recognized as Safe (GRAS), 
microorganisms are classified as safe and are one 
of the most important current biotechnology 
tools, increasingly becoming a valid alternative 
in mycotoxin decontamination. Saccharomyces 
cerevisiae and lactic acid-producing bacteria 
(LAB) have been used in functional foods, 
probiotics, as well as potential microorganisms 
for mycotoxin decontamination, due to their 
AFB1 binding capability (Pereyra et al., 2015; 
Armando et al., 2011; Pizzolitto et al., 2012).  
 
According to Juodeikiene et al. (2012), S. 
cerevisiae strains with high binding capacity to 
mycotoxins may be employed as additives in 
small amounts in many foodstuffs without 
changing final product characteristics. The 
inclusion of viable strains in fish diet modifies 
the intestinal flora by producing antimicrobial 
substances and enzymes and creating 
competition with the undesirable microorganisms 
for adhesion sites and nutrients (Fuller, 1989; 
Cyrino et al., 2010).   
 
For a strain to be considered probiotic, it must 
meet certain principles, namely: survive the 
acidic and basic conditions of the gastrointestinal 
tract; adhere to mucous membranes; proliferate 
in intestinal conditions, competing with the 





CFU/mL); not be 
associated with disease; possess genetic stability 
during processing and show the absence of 
undesirable organoleptic food properties (Fuller, 
1989; D'Aimmo et al., 2007). 
 
The effectiveness of probiotics on animal health 
has been repeatedly studied. However, besides 
probiotic capability, it is necessary to evaluate 
the role of different probiotic strains in the 
mycotoxin adsorption processes (Armando et al., 
2011; Pizzolitto et al., 2011). In this sense, the 
searc for natural compounds that can perform 
such functions is important for technological and 
economic development and animal health. Thus, 
in this setting, the present study aimed to 
evaluate the in vitro probiotic and adsorbent 
potential of Saccharomyces cerevisiae regarding 
aflatoxin B1 in conditions mimicking fish 
intestinal tract conditions, for applications in 
fishery activities. 
 
MATERIAL AND METHODS 
 
Three yeast strains were used, two obtained from 
a brewery, namely S. cerevisiae RC1 and S. 
cerevisiae RC3, and one from a pisciculture 
environment, S. cerevisiae A8L2, obtained from 
the Food Microbiology Laboratory culture 
collection at the Food Research and Processing 
Center (NUEPPA/CCA/UFPI). The selected 
strains were used for the probiotic testing and 
AFB1 adsorption assays. Four strains of 
pathogenic bacteria provided by the Veterinary 
Microbiology Laboratory at the Center for 
Agricultural Sciences (CCA/UFPI) were used for 
the co-aggregation and antibacterial tests, 
 namely Escherichia coli, Salmonella spp., 
Staphylococcus aureus and Pseudomonas spp. 
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Selected yeasts were subjected to in vitro tests, 
namely homologous inhibition, self- aggregation, 
co-aggregation, antibacterial activity and 
viability to gastrointestinal conditions, to assess 
their probiotic potential. Subsequently, the yeasts 
were subjected to an AFB1 adsorption test. The 
viability assays were performed in artificially 
gastrointestinal conditions simulating pH and 
food transit time conditions in fish known as 
tambaquis. For this test, three Saccharomyces 
cerevisiae strains were investigated, and the 
cross-streaking method described by Muzzolón 








Figure 1. Homologous inhibition assay between Saccharomyces cerevisiae strains using cross streaking 
method a) Vertical streak of tested strains in Petri dishes containing yeast extract peptone dextrose (YPD) 
agar. b) Horizontal and vertical streaks of tested strains. c) Incubation of Petri dishes at 37°C for 48h. 
 
Self-aggregation capacity assays were carried out 
according to the methodology described by Kos 
et al. (2003). After a Saccharomyces cell count 
using a double mirrored Neubauer chamber 
(Herka®) for initial standardization of the 
inoculate at 10
7
cells/mL, the yeast strains were 
incubated for 24h at 37ºC in 4.0ml of YPD broth. 
After incubation, the strains were centrifuged at 
5.000 rpm for 10 minutes, the supernatants were 
discarded, and the cells were washed with 
phosphate buffered saline (PBS) at pH 7.2. The 
resulting pellets were then resuspended in 4.0mL 
PBS, pH 7.2, and subjected to homogenization in 
a vortex shaker. 
 
To assess self-aggregation capacity, the contents 
were incubated without agitation for two hours at 
37ºC in a temperature-controlled culture oven 
(model 002CB, Fanem LTDA
®
). Subsequently, 
2.0mL of the upper part of the solution were 
collected and optical density (OD) was measured 
at 600nm in a spectrophotometer (Model SP -
220, Biospectro). The initial OD was 
standardized to approximately 0.5. The 
percentage of self-aggregation was expressed by 
the following Equation 1: Self-aggregation %=1-
(At/A0) x 100, where densities (OD) measured at 
time zero (A0) and two hours after the rest time 
(At).  
 
The yeast preparation method for the co-
aggregation assays was the same as that used for 
the self-aggregation assays, following the 
methodology proposed by Xu et al. (2009). Four 
strains of bacteria associated with infections in 
fish were used: Escherichia coli; Salmonella 
spp., Staphylococcus aureus and Pseudomonas 
spp. The inoculate of each pathogenic bacteria 
were obtained in nutrient broth after 24 hours in 
a temperature-controlled oven at 37°C. 
Subsequently, the bacterial suspensions were 
subjected to centrifugation at 5.000rpm for 10 
minutes, the supernatants were discarded and the 
cells resuspended with PBS, pH 7.2. 
 
Initial standardizations of both the yeast and the 
bacteria suspensions were carried out in a 
spectrophotometer at 600nm, to an OD of 0.7, 
and densities were then adjusted by adding PBS 
to the more concentrated suspensions. Equal 
volumes (2.0mL) of the yeast and pathogenic 
bacteria strains were transferred to a test tube, 
homogenized in a vortex shaker and incubated at 
37°C for two hours without stirring. Finally, the 
absorbances of the mixtures (ODmix) were 
measured at 600nm. Co-aggregations were 
calculated according to the following Equation 2:  
 
Co-aggregation %= [1 − ODmix/(ODyeast+ 
ODbacteria)/2] × 100 
 
The antibacterial activity tests were conducted by 
the Slab test method on YPD agar in accordance 
with the methodology proposed by Strus (1998). 
The pathogenic bacteria strains used in this 
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aureus and Pseudomonas spp. The bacteria 
suspensions were standardized with the aid of a 
spectrophotometer at 600nm to an OD of 0.7. 
After standardization, the bacteria were plated on 
nutrient agar plates and incubated at 37°C for 
48h. YPD agar pieces of 14mm diameter 
containing yeasts grown at 37°C after 48h were 
cut under aseptic conditions and added to the 
plates containing the bacteria strains. Each 
treatment was performed in duplicate. 
Interpretation of the results was performed after 
24h incubation at 37°C, by the appearance or 
non-appearance of clear zones around each 
strain, indicating the inhibitory effect of a 
microorganism on the other. The growth 
inhibition zone diameters around the agar plates 
were measured and the results given in mm, by 
subtracting the diameter of the agar plate. 
 
Suspensions of each S. cerevisiae isolate strain 
(RC1, RC3 and A8L2) were prepared in peptone 





using a Neubauer chamber, following the 
proposal by Van der Aa Kuhle et al. (2005) with 
minor modifications. Subsequently, 900uL of 
YPD broth was added to 100mL of each solution 
and the mixture was adjusted to pH 2.0 by 
addition of hydrochloric acid, to simulate the 
stomach conditions of the tambaqui (Rotta, 
2003).
 
Solutions containing the inoculates were 
subjected to constant agitation at 150rpm on a 
shaking table (SL-180/DT model, Solab
®
) with 
room temperature maintained at around±30°C. 
At time points of 4, 8 and 12 hours, 100uL 
aliquots were obtained from each culture and 
viable cell count by decimal dilution and seeding 
by spreading on YPD agar surface. The assay 
was performed in duplicate.  
 
To determine the viability and tolerance of yeast 
strains to tambaqui intestine biliary conditions, a 
test was performed using a methodology similar 
to the assay regarding tolerance to low pH 
conditions. YPD broth supplemented with ox 
bile at 0.5% (Sigma-Aldrich
®
) was used, 
adjusted to pH 7.0 by addition of a 1mol/L
 
sodium hydroxide solution, simulating the 
intestinal conditions of omnivores (Rotta, 2003). 
 
The AFB1 adsorption assay was performed 
according to Bueno et al. (2007) and Poloni et al. 
(2015) with minor modifications. The initial 
AFB1 solution used in the assay was resuspended 
in acetonitrile from a dry core extract of known 
concentration (14.7μg AFB1). Stock AFB1 
solutions (10 and 25ng/mL) were prepared in 
PBS (pH 2.0 to 7.0). The yeast used in the 
previously described assays were previously 
prepared in YPD broth and standardized after 
growth with the aid of a Neubauer chamber at 
10
7
cells/mL. Subsequently, 1.0mL of each strain 
solution was placed into microtubes and 
centrifuged for 15min at 5.000rpm at room 
temperature. The samples were then washed with 
distilled water and subjected to centrifugation in 
the same conditions. After centrifugation, 1mL 
of a PBS solution containing AFB1 was added, 
initially at pH 2.0, to simulate tambaqui stomach 
acidity, incubated at 30
o
C for 30 minutes and 
then stirred manually. The pellets were 
centrifuged, and 1.0mL of PBS at pH 7.0 
containing AFB1 at the tested concentrations of 
10 and 25ng/mL were added. The microtubes 
were then incubated at 30°C for 60 minutes and 
subjected to manual shaking every five minutes, 
pelleted by centrifugation for 15min at 5.000rpm 
at room temperature, and the supernatant 
containing unbound mycotoxins was collected 
and stored for analysis of the  
adsorption percentage by high-performance 
liquid chromatography (HPLC).  
 
AFB1 detection and quantification was performed 
by a High Performance Liquid Chromatography 
(Waters e2695; Waters, Milford, MA, USA) with 
excitation and emission wavelengths at 360nm 
and 440nm, respectively, equipped with a C18 
reverse phase silica gel column (150 x 4.6mm, 
5.0µm particle size, Phenomenex, Luna, 
Torrance, CA, USA). Aliquots (100uL) of the 
sample extracts were homogenized in 350uL of a 
derivatizing solution composed of trifluoroacetic 
acid:glacial acetic acid:water (20:10:70, v/v) 
(Trucksess et al., 1994). The mobile phase was 
an isocratic system composed of 
acetonitrile:methanol:water (17:17:66 v/v) at a 
flow rate of 1.5mL/min.  
 
The toxin quantification curve was performed by 
measuring peak heights and performing their 
interpolation to a calibration curve constructed 
with different concentrations of the AFB1 
standard, dissolved in acetonitrile, from where 
the limits of detection and quantification of the 
technique were extracted. Adsorbed AFB1 
quantifications were established by the 
correlation between the peak areas of the 
samples and the standard curve. To calculate the 
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adsorption percentages, the following Equation 3 
was used: Adsorption % = (area of the 
supernatant / area of the toxin in the positive 
control) x 100. 
 
The treatments were distributed in a completely 
randomized 3x4 factorial design (three yeast 
strains, four viability times) for the viability test 
and 3x2 (three yeast strains, two AFB1 
concentrations) for the adsorption test, with two 
replicates per treatment. The colony counts 
obtained in the gastrointestinal viability test 
conditions were analyzed and the number of 
yeast cells transformed on a logarithmic scale 
log10
(x + 1)
 and then applied to the analysis of 
variance. The data obtained (co-aggregation, 
viability and AFB1 adsorption) were analyzed 
according to the SAS 9.0 procedures and 
subjected to an analysis of variance and mean 
comparison by Student–Newman–Keuls (SNK) 
considering a 5% level of significance. 
 
RESULTS AND DISCUSSION 
 
In the homologous inhibition assay, the tested S. 
cerevisiae strains, A8L2, RC1 and RC3, 
naturally developed between the grooves on the 
Petri dishes without the presence of a halo 
between them, as shown in Figure 2.  
 
The results observed herein, therefore, allow for 
the use of the three strains grouped together, 
since they did inhibit one another and, if used 
together, may result in potentiating effects. Such 
data differ from the earlier report which were 
conducted by Muzzolón (2010), that 
demonstrated that 31% of the Enterococcus sp. 
evaluated in inhibited growth of all the LAB 
strains tested. This homologous inhibition 
property is important because it allows the use of 
a mixture of strains to act together as probiotics 
(De Angelis et al., 2006).  
 
 
Figure 2. Homologous inhibition between 
Saccharomyces cerevisiae strains. Growth was 
considered negative when no halo or inhibition 
(<5mm). A8L2=
 
S. cerevisiae obtained from a 
pisciculture environment; RC1 and RC3= S. 
cerevisiae obtained from a brewery. 
 
With regard to the self-aggregation assay (Table 
1) the CR3 strain was more efficient, displaying 
87.1% self-aggregation, being considered strong, 
while strains A8L2 and RC1 showed 76.0% and 
78.1%, respectively, although still positive 
according to the classification proposed by Kos 
et al. (2003). 
 
Table 1. Capacity self-aggregation between Saccharomyces cerevisiae strains (means±standard deviation) 




 1- (OD600 t1/ OD600 




A8L2 0.586±0.013 0.140±0.050 76.0±9.10 + 
RC1 0.545±0.007 0.119±0.004 78.1±0.62 + 
RC3 0.576±0.022 0.074±0.022 87.1±3.33 ++ 
1Initial optical density; 2Optical density after two hours; 3(-) = aggregation ≤ 60, (+) = aggregation< 80 > 60, (++) = 
aggregation ≥ 80; A8L2 = S. cerevisiae obtained from a pisciculture environment; RC1 and RC3 = S. cerevisiae 
obtained from a brewery. 
 
Similar results were reported by Pizzolitto et al. 
(2012) when strains from chicken feed were 
used, it was found the percentage of 68.4 to 
84.7% of self-aggregation. Thus, the self-
aggregation percentage observed herein thus 
indicate that the three investigated strains show 
good capacity to unite, a desirable characteristic 
for probiotic species (Muzzolón, 2010). 
Consequently, the results of homologous 
inhibition and self-aggregation capacity favor the 
possible use of these strains grouped the same 
commercial product formulations.  
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Although all tested strains are the same species, 
individual variations (P<0.05) between strains 
were observed with regard to co-aggregation 
capacity (Table 2) alongside the pathogenic 
bacteria used in the test.  
 
For E. coli, the A8L2 strain was the most 
efficient, while for Salmonella spp. both A8L2 
and RC3 showed higher performance. The RC1 
and RC3 strains showed higher percentage of co-
aggregation in tests conducted with S. aureus and 
Pseudomonas spp. (Table 2). These results were 
more effective than those obtained by Pizzolitto 
et al. (2012)
 
who found co-aggregation values 
between 25.3% and 36.0% for S. cerevisiae and 
S. aureus strains. In addition, only one of the 
strains investigated in that study was able to 
achieve a reasonable level of aggregation 
(between 15-26%) with the investigated 
pathogens, of which three were tested in the 
present study (E. coli, S. aureus and Salmonella 
spp.).  
 
Table 2. Co-aggregation between Saccharomyces cerevisiae and pathogenic strains of bacteria 
Strains Co-aggregation (%) 




























CV (%) 1.69 2.58 3.39 2.64 
Means within the same column followed by different letters differ significantly as per the SNK test 
(P<0.05). A8L2 =
 
S. cerevisiae obtained from a pisciculture environment; RC1 and RC3 = S. cerevisiae 
obtained from a brewery. 
 
For the antibacterial activity test, only the A8L2 
strain was able to inhibit Salmonella spp., 
showing an 11mm diameter inhibition, with no 
significant effect on the other tested strains. The 
A8L2 strain also presented one of the highest co-
aggregation percentages (36.14%) with the 
bacterium Salmonella spp. This is important, 
since, in order to be considered a probiotic, the 
strain should be able to inhibit pathogens that 
occur in the digestive tract of animals, as is the 
case of Salmonella spp. (Fuller, 1989). 
Keersmaecker et al. (2006)
 
in their study also 
observed the occurrence of antimicrobial activity 
by a Lactobacillus rhamnosus strain against 
Salmonella enterica, while Draksler et al. (2004) 
observed that only 0.7% of the Bifidobacterium, 
Lactobacillus and Enterococcus strains used as 
probiotics in food for goats showed antimicrobial 
activity against S. typhimurium and E. coli, with 
the remaining 93.3% being inactive in this 
regard. 
 
Table 3 and 4 display the survival of S. 
cerevisiae strains in the in vitro viability assays 
regarding simulated tambaqui gastrointestinal 
conditions. These results of in vitro viability 
assays regarding simulated tambaqui 
gastrointestinal conditions are essential for the 
selection of probiotic strains, since these 
compounds should be tolerant to the presence of 
stomach acid and bile salts in the intestine 
(Gueimonde and Salminen, 2006). 
 
All investigated strains showed high survival 
percentages (Table 3) in the simulated tambaqui 
stomach pH conditions (pH 2.0). However, both 
factors (strain vs. time) showed significant 
interaction (P=0.0317), resulting in significant 
variations among the tested strains at the 
analyzed time points. The A8L2 strain proved to 
be the most stable (P>0.05) from the beginning 
to the end of the test, while RC1 and RC3 
showed variations during the test timeframe. The 
acidic pH value applied this test may have 
influenced RC1 and RC3 viabilities between 4h 
and 8h, with a decrease in cell count during this 
period (Table 3). Soon after, however, the viable 
cells became stable, possibly allowing for the 
multiplication of certain cells in this medium, 
demonstrated by the increased final count.  
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Table 3. Effect of the simulated passage at stomach tambaqui pH (pH 2.0) on the viability of 
Saccharomyces cerevisiae strains  
Variable Strains Time (hours) 




  0h 4h 8h 12h   
Viability 




























 7.80  
Means
1
  7.97 7.52 7.35 7.81   
1 Means followed by different lower-case letters within the same column for the same time differ significantly as per 
the SNK test (P<0.05). Means followed by different capital letters in the same line, for the same strain, differ 
significantly as per the SNK test (P<0.05). A8L2 = S. cerevisiae obtained from a pisciculture environment; RC1 and 
RC3 = S. cerevisiae obtained from a brewery; CFU = colony-forming unit. 
 
Table 4 indicates further interactions between the 
analyzed factors (P=0.0062). The A8L2 strain 
proved to be the most effective in these 
conditions, given that it showed continuous cell 
growth during all studied time points (4h, 8h and 
12h), with a final value of 9.07 CFU/mL. In this 
sense, Nayak (2010)
 
argues that an ideal 
probiotic is able to establish, multiply and 
colonize the intestinal epithelium of the host. 
 
Table 4. Effect of the simulated passage at intestinal tambaqui pH (pH 7.0) on the viability of 
Saccharomyces cerevisiae strains  
Variable Strains 
Time (hours) 


































 7.47  
Means
1
  7.26 6.91 7.85 8.48   
1 Means followed by different lower-case letters within the same column for the same time differ significantly as per 
the SNK test (P<0.05). Means followed by different capital letters in the same line, for the same strain, differ 
significantly as per the SNK test (P<0.05). A8L2 = S. cerevisiae obtained from a pisciculture environment; RC1 and 
RC3 = S. cerevisiae obtained from a brewery; CFU = colony-forming unit. 
 
The tolerance results in simulated tambaqui 
stomach and intestine conditions are in 
agreement with those described by Armando et 
al. (2011) who observed that four S. cerevisiae 
strains isolated from food and intestines of pigs 
were able to survive under simulated 
gastrointestinal conditions of farm animals. 
Likewise, in the present study, the A8L2 strain 
was able to withstand the acidic conditions of the 
simulated stomach and intestine conditions and 
showed high concentrations at the end of the 
assay. Table 5 shows the AFB1 adsorption 
capacity for the S. cerevisiae strains investigated 
herein. The yeasts were tested at two different 
AFB1 concentrations. 
 
Table 5. Adsorption (%) different levels (10 and 25ng/mL)
 
of aflatoxin B1 by Saccharomyces cerevisiae 
strains 















 RC1 14.53  4.69 9.61
b
  









   
1 Means followed by different letters differ significantly as per the SNK test (P<0.05 ). A8L2 = S. cerevisiae obtained 
from a pisciculture environment; RC1 and RC3 = S. cerevisiae obtained from a brewery. 
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No interaction among the factors was found for 
this variable (P>0.05). The A8L2 strain was 
statistically more effective (P<0.005) regarding 
adsorption capacity, of 21.19% and 19.77% 
adsorption for the two AFB1 concentrations, 
respectively, resulting in an overall mean value 
of 20.48%. Similar values were reported by 
Pinheiro et al. (2017) when simulating the pH of 
the stomach and intestine of Nile tilapia 
(Oreochromis niloticus) with PBS, who found 
that the efficiency of the anti-mycotoxin capacity 
of dry S. cerevisiae brewery yeasts at different 
pH values ranged from 12.4 to 21.6% at 
1000ng/mL AFB1. 
 
Armando et al. (2011) using the same yeast cell 
concentrations as the present study verified that 
AFB1adsorption percentages vary between S. 
cerevisiae strains according to the AFB1 
concentration, and found values ranging from 
16.4 to 82% for 50ng/mL; 21.3 to 48.7% for 
100ng/mL and 20.2 to 65.5% for 500ng/mL
 
AFB1. However, in contrast to the results 
presented by those researchers, no difference 
(P>0.05) was observed between the adsorption 
values of S. cerevisiae strains at 10 and 25ng/mL 
in the present study. Given these data, it is clear 
that the amount of adsorbed toxin in different 
studies is dependent on concentration and 
binding level, varying between strains, indicating 
the specific nature of these microorganisms in 
the adsorption process (Pizzolitto et al., 2012). 
Thus, the best way to evaluate the adsorption 
efficiency of a microorganism is by using more 
than one toxin concentration.  
 
The differences in adsorption observed between 
the three S. cerevisiae strains when exposed to 
different media conditions can be explained by 
structural differences in yeast cell walls, which 
are formed by beta-glucans and mananoproteins, 
specific binding sites for toxins and pathogenic 





Based on the results, the investigated S. 
cerevisiae strains show desirable probiotic 
characteristics and AFB1 adsorption capacity. 
Thus, the inclusion of these strains in tambaqui 
diets may improve health aspects and reduce the 
amount of AFB1 occasionally ingested through 
contaminated feed. However, in vivo studies with 
these yeast species should be conducted for a 
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